Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Head & Neck Cancer Diagnostics Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of head and neck cancer worldwide
5.1.1.2. Rise in government and private body initiatives for cancer diagnostics
5.1.1.3. Increased approval for head & neck cancer diagnostics
5.1.2. Restraints
5.1.2.1. High cost of the devices and unfavorable reimbursement scenarios
5.1.3. Opportunities
5.1.3.1. New advancements and innovations in diagnostic methodology
5.1.3.2. Large research funding in oncological advancement
5.1.4. Challenges
5.1.4.1. Dearth of trained professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Head & Neck Cancer Diagnostics Market, by Diagnostic Method
6.1. Introduction
6.2. Bioscopy Screening
6.3. Blood Tests
6.4. Dental Diagnostic
6.5. Diagnostic Imaging
6.6. Endoscopy Screening

7. Head & Neck Cancer Diagnostics Market, by End User
7.1. Introduction
7.2. Diagnostic Centers
7.3. Hospitals

8. Americas Head & Neck Cancer Diagnostics Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Head & Neck Cancer Diagnostics Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Head & Neck Cancer Diagnostics Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. AbbVie Inc.
12.1.2. AdDent, Inc.
12.1.3. Bristol Myers Squibb Company
12.1.4. Canon Inc.
12.1.5. Carestream Health Inc. by Koninklijke Philips N.V.
12.1.6. Esaote S.p.A.
12.1.7. FUJIFILM Holdings Corporation
12.1.8. General Electric Company
12.1.9. KARL STORZ SE & Co. KG
12.1.10. Merck KGaA
12.1.11. Olympus Corporation
12.1.12. Optim LLC
12.1.13. Shimadzu Corporation
12.1.14. Siemens AG
12.1.15. Xoran Technologies LLC
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. HEAD & NECK CANCER DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HEAD & NECK CANCER DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2023 VS 2030 (%)
FIGURE 8. HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 10. HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. HEAD & NECK CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. HEAD & NECK CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. HEAD & NECK CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 6. HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY BIOSCOPY SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DENTAL DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY ENDOSCOPY SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 12. HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 21. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 22. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 24. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. CHINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 34. CHINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. INDIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 36. INDIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. JAPAN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 40. JAPAN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. THAILAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 52. THAILAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. DENMARK HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 59. DENMARK HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. EGYPT HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 61. EGYPT HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. FINLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 63. FINLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 65. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 67. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. ITALY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 71. ITALY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. NORWAY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 77. NORWAY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. POLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 79. POLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. QATAR HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 81. QATAR HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. SPAIN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 89. SPAIN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. TURKEY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 95. TURKEY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. HEAD & NECK CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 101. HEAD & NECK CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 102. HEAD & NECK CANCER DIAGNOSTICS MARKET LICENSE & PRICING